Literature DB >> 2633713

[Sensitivity of Yersinia pestis to antibiotics: 277 strains isolated in Madagascar between 1926 and 1989].

B Rasoamanana1, P Coulanges, P Michel, N Rasolofonirina.   

Abstract

The antimicrobial susceptibility of 277 strains of Yersinia pestis was studied using broth microdilution panel. In recent strains, trimethoprim, cotrimoxazole and ampicillin were the most active of the antibiotics tested (MICs less than 2 mg/l). All strains were inhibited by 16 mg/l of kanamycin and sulfamethoxazole, 32 mg/l of sulphadiazine and sulfanilamide, and 64 mg/l of sulfamethoxypyridazine. Doxycycline, minocycline, chloramphenicol, demeclocycline, tetracycline, oxytetracycline and chlortetracycline were equally active but some of strains were resistant (13% for tetracycline; 32.5% for oxytetracycline; 84.5% for chlortetracycline). Analysis of MICs in relation with time (comparison of the two period: 1926-1948 and 1948-1989) evidenced a trend towards a decrease in susceptibility to cyclines prime generation. Sulphonamides and streptomycin preserve the some efficacity on Y. pestis but we have to notice the possible existence of resistant strain on high level with streptomycin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2633713

Source DB:  PubMed          Journal:  Arch Inst Pasteur Madagascar        ISSN: 0020-2495


  12 in total

1.  Evaluation of imipenem for prophylaxis and therapy of Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague.

Authors:  Henry S Heine; Arnold Louie; Jeffrey J Adamovicz; Kei Amemiya; Randy L Fast; Lynda Miller; Steven M Opal; John Palardy; Nicolas A Parejo; Fritz Sörgel; Martina Kinzig-Schippers; George L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2014-03-31       Impact factor: 5.191

2.  Comparative efficacies of candidate antibiotics against Yersinia pestis in an in vitro pharmacodynamic model.

Authors:  Arnold Louie; Brian Vanscoy; Weiguo Liu; Robert Kulawy; David Brown; Henry S Heine; George L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2011-04-12       Impact factor: 5.191

3.  In vitro antimicrobial susceptibilities of strains of Yersinia pestis.

Authors:  M D Smith; D X Vinh; T T Nguyen; J Wain; D Thung; N J White
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

4.  Use of an in vitro pharmacodynamic model to derive a moxifloxacin regimen that optimizes kill of Yersinia pestis and prevents emergence of resistance.

Authors:  A Louie; H S Heine; B VanScoy; A Eichas; K Files; S Fikes; D L Brown; W Liu; M Kinzig-Schippers; F Sörgel; G L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2010-11-29       Impact factor: 5.191

5.  In vitro activities of 14 antibiotics against 100 human isolates of Yersinia pestis from a southern African plague focus.

Authors:  J A Frean; L Arntzen; T Capper; A Bryskier; K P Klugman
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

6.  Assessment of a fluoroquinolone, three beta-lactams, two aminoglycosides, and a cycline in treatment of murine Yersinia pestis infection.

Authors:  S P Bonacorsi; M R Scavizzi; A Guiyoule; J H Amouroux; E Carniel
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

7.  Adenovirus-mediated delivery of an anti-V antigen monoclonal antibody protects mice against a lethal Yersinia pestis challenge.

Authors:  Carolina Sofer-Podesta; John Ang; Neil R Hackett; Svetlana Senina; David Perlin; Ronald G Crystal; Julie L Boyer
Journal:  Infect Immun       Date:  2009-01-05       Impact factor: 3.441

8.  Impact of resistance selection and mutant growth fitness on the relative efficacies of streptomycin and levofloxacin for plague therapy.

Authors:  Arnold Louie; Mark R Deziel; Weiguo Liu; George L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2007-05-21       Impact factor: 5.191

Review 9.  Antibiotic Therapy of Plague: A Review.

Authors:  Florent Sebbane; Nadine Lemaître
Journal:  Biomolecules       Date:  2021-05-12

10.  Metallacarborane Derivatives Effective against Pseudomonas aeruginosa and Yersinia enterocolitica.

Authors:  Wieslaw Swietnicki; Waldemar Goldeman; Mateusz Psurski; Anna Nasulewicz-Goldeman; Anna Boguszewska-Czubara; Marek Drab; Jordan Sycz; Tomasz M Goszczyński
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.